19.09  0 (0%)		06-05 16:00
Open: 19.09 High: 19.09 Volume: 0		Pre. Close: 19.09 Low: 19.09 Market Cap: 118(M)

Short term
Mid term
Targets	6-month :	22.33	1-year :	26.09
Resists	First :	19.12	Second :	22.33
Pivot price	18.97
Supports	First :	18.93	Second :	18.81
MAs	MA(5) :	19.09	MA(20) :	18.94
	MA(100) :	18.68	MA(250) :	16.68
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	87.7	D(3) :	91.4
RSI	RSI(14): 75.4
52-week	High :	19.12	Low :	13.61

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ FONR ] has closed below upper band by 23.0%. Bollinger Bands are 32.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	19.13 - 19.23	19.23 - 19.31
Low:	18.82 - 18.95	18.95 - 19.06
Close:	18.91 - 19.1	19.1 - 19.26

FONAR Corporation, along with its affiliated entities, is primarily engaged in the research, development, manufacturing, and commercialization of magnetic resonance imaging (MRI) systems within the United States. These sophisticated scanners are instrumental in the detection and diagnosis of various human diseases. The company's operations are divided into two distinct divisions: a Medical Equipment segment and a Physician Management and Diagnostic Services segment. A flagship product is their innovative Upright MRI scanner, which offers the unique capability of imaging patients in weight-bearing postures such as standing, sitting, bending, or traditional supine positions. This allows for the observation of conditions that manifest under natural gravitational stress. Furthermore, under its Physician Management segment, FONAR provides a comprehensive suite of non-medical management and administrative support services. These encompass areas like billing and collections, professional credentialing, contract negotiation, compliance consultation, IT procurement, human resources (including hiring, training, and supervision of non-clinical staff), medical record archival, office space and equipment provision, maintenance, accounting, and assistance with regulatory adherence, as well as the formulation and execution of practice growth and marketing initiatives. FONAR maintains a significant presence in diagnostic imaging services, directly owning and operating five facilities in Florida. Additionally, it oversees the management of 39 MRI scanning centers, with 25 located in New York and 14 throughout Florida. The company strategically markets its advanced MRI technology to both independent diagnostic imaging centers and hospitals. Incorporated in 1978, FONAR Corporation is headquartered in Melville, New York.

Tue, 09 Jun 2026
FONAR CORP (FONR) director Claudette Chan reports direct holding of 106 shares - Stock Titan

Tue, 09 Jun 2026
FONAR (NASDAQ: FONR) director Claudette Chan discloses 106 common shares on Form 3 - Stock Titan

Tue, 09 Jun 2026
FONAR (FONR) director Ronald G. Lehman reports holding 4,330 shares - Stock Titan

Tue, 09 Jun 2026
FONAR (FONR) director Ronald G. Lehman granted stock bonuses under 2010 plan - Stock Titan

Tue, 09 Jun 2026
Ronald Lehman (NASDAQ: FONR) submits initial Form 3 as director - Stock Titan

Mon, 08 Jun 2026
FONAR (FONR) EVP Bonanni reports 54,253 common shares held - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	6 (M)
Shares Float	6 (M)
Held by Insiders	16.3 (%)
Held by Institutions	40.3 (%)
Shares Short	66 (K)
Shares Short P.Month	42 (K)

EPS	1
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	27.01
Profit Margin	6.3 %
Operating Margin	9.2 %
Return on Assets (ttm)	2.7 %
Return on Equity (ttm)	5.4 %
Qtrly Rev. Growth	-2.6 %
Gross Profit (p.s.)	6.87
Sales Per Share	17.07
EBITDA (p.s.)	2.23
Qtrly Earnings Growth	-37.1 %
Operating Cash Flow	8 (M)
Levered Free Cash Flow	1 (M)

PE Ratio	19.09
PEG Ratio	0
Price to Book value	0.7
Price to Sales	1.11
Price to Cash Flow	15.37

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.